# Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

> **NCT01078571** · — · COMPLETED · sponsor: **Abbott** · enrollment: 705 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** adalimumab (HUMIRA®)

## Key facts

- **NCT ID:** NCT01078571
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 705 (ACTUAL)
- **Last updated:** 2011-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078571, "Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01078571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*